Simple cap could stop deadly hospital infections
NCT ID NCT07430215
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether using special disinfectant caps on central venous catheters can lower the rate of bloodstream infections in intensive care patients. About 120 adults in a neurological ICU will be monitored. The caps are pre-treated with alcohol and are meant to block germs from entering the bloodstream through the catheter.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- disinfectant caps (pre-treated with 70% isopropanol)
- What this could lead to
- If it works, this could provide a simple, low-cost way to prevent dangerous bloodstream infections in hospital patients with central lines.
- What could go wrong
- This is a small, single-center quality improvement study, not a large randomized trial. The results may not apply to other hospitals or patient groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 120 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2026
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
All patient admissions to the neurological intensive care unit within one year are prospectively recruited from the patient population of the BDH Clinic in Hessisch Oldendorf. Recruitment is carried out through continuous screening of all newly admitted patients who meet the inclusion criteria. In addition, retrospective data collection is performed. Only patient data whose relatives have consented to the processing of routine data for quality assurance and research purposes are analyzed.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Stay in the neurological intensive care unit * Presence of a central venous catheter (CVC) * Written consent from the legal representative of the study participant (if the participant lacks capacity to consent) and/or from the study participant (if the participant is capable of consenting) for the use of routine data for quality and research purposes Exclusion Criteria: * written objection to the use of routine data for quality and research purposes
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Central line-associated bloodstream infections are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Institute for Neurehabilitative Resaerch
Hessisch Oldendorf, Lower Saxony, 31840, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.